Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-01 11:05 am Sale | 2024-09-30 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,103,430 17.000% | -5,906 (-0.14%) | Filing History |
| 2024-10-18 5:23 pm Purchase | 2024-09-30 | 13G | Rapport Therapeutics, Inc. Common Stock RAPP | JOHNSON & JOHNSON JNJ | 2,498,051 6.800% | 2,498,051 (New Position) | Filing History |
| 2024-10-18 4:47 pm Unchanged | 2024-09-30 | 13G | MeiraGTx Holdings plc MGTX | JOHNSON & JOHNSON JNJ | 6,641,064 8.600% | 0 (Unchanged) | Filing History |
| 2024-07-30 9:06 pm Purchase | 2024-04-10 | 13G | Rallybio Corporation RLYB | JOHNSON & JOHNSON JNJ | 3,636,363 8.800% | 3,636,363 (New Position) | Filing History |
| 2024-05-20 5:17 pm Sale | 2024-05-17 | 13G | Kenvue Inc. KVUE | JOHNSON & JOHNSON JNJ | 0 0.000% | -182,329,550 (Position Closed) | Filing History |
| 2024-04-10 5:12 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | JOHNSON & JOHNSON JNJ | 1,979,173 10.700% | 1,979,173 (New Position) | Filing History |
| 2024-02-13 5:07 pm Sale | 2023-12-29 | 13G | Johnson & Johnson JNJ | The Vanguard Group | 229,372,559 9.530% | -17,454,062 (-7.07%) | Filing History |
| 2024-02-02 5:07 pm Sale | 2023-12-31 | 13G | BiomX Inc. PHGE | JOHNSON & JOHNSON JNJ | 211,340 4.600% | -2,000 (-0.94%) | Filing History |
| 2024-02-02 4:52 pm Sale | 2023-12-31 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,109,336 19.200% | -237 (-0.01%) | Filing History |
| 2024-02-02 4:32 pm Purchase | 2023-12-31 | 13G | Nanobiotix S.A. NBTX | JOHNSON & JOHNSON JNJ | 5,623,816 11.900% | 5,623,816 (New Position) | Filing History |
| 2024-01-30 12:46 pm Sale | 2023-12-31 | 13G | Johnson & Johnson JNJ | STATE STREET CORP STT | 132,996,283 5.520% | -9,451,661 (-6.64%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Johnson & Johnson JNJ | BlackRock Inc. BLK | 186,308,341 7.700% | -12,494,428 (-6.28%) | Filing History |
| 2024-01-24 12:51 pm Purchase | 2023-12-31 | 13G | Kenvue Inc. KVUE | JOHNSON & JOHNSON JNJ | 182,329,550 9.500% | 182,329,550 (New Position) | Filing History |
| 2023-02-10 07:53 am Sale | 2022-12-31 | 13G | Johnson & Johnson JNJ | STATE STREET CORP STT | 142,447,944 5.450% | -2,548,183 (-1.76%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | Johnson & Johnson JNJ | The Vanguard Group | 246,826,621 9.440% | 12,043,989 (+5.13%) | Filing History |
| 2023-01-31 1:58 pm Sale | 2022-12-31 | 13G | Johnson & Johnson JNJ | BlackRock Inc. BLK | 198,802,769 7.600% | -1,218,583 (-0.61%) | Filing History |
| 2023-01-27 11:12 am Sale | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | JOHNSON & JOHNSON JNJ | 3,670,516 8.200% | -89,118 (-2.37%) | Filing History |
| 2023-01-11 1:00 pm Unchanged | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | JOHNSON & JOHNSON JNJ | 2,449,183 4.980% | 0 (Unchanged) | Filing History |
| 2022-11-14 2:40 pm Purchase | 2022-11-09 | 13G | MeiraGTx Holdings plc MGTX | JOHNSON & JOHNSON JNJ | 6,641,064 13.700% | 3,742,514 (+129.12%) | Filing History |
| 2022-02-14 12:37 pm Purchase | 2021-12-31 | 13G | Johnson & Johnson JNJ | STATE STREET CORP STT | 144,996,127 5.510% | 966,493 (+0.67%) | Filing History |